Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals
- PMID: 3816917
- DOI: 10.1007/BF00613512
Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals
Abstract
The effect of two different doses of nitrendipine on plasma digoxin levels, urinary recovery and systolic time intervals was investigated in 8 healthy volunteers. Following a loading dose, digoxin 0.25 mg b.d.p.o. was given alone for 2 weeks. Then 0.25 mg digoxin b.d. was administered for two 1-week periods combined with nitrendipine 10 mg or 20 mg once daily. The study was completed with another digoxin monotherapy phase lasting 7 days. Nitrendipine 20 mg daily led to a significant increase in plasma digoxin levels and in its area under the plasma concentration-time curve AUC (0-12) was 9.7 ng ml-1h when digoxin alone was given and 11.2 ng ml-1h on co-administration of the calcium antagonist. Urinary recovery and renal clearance of digoxin were slightly but not significantly increased by nitrendipine. Nitrendipine 10 mg once daily caused a small, insignificant tendency to elevate the plasma digoxin level. Nitrendipine co-administration (10 and 20 mg once daily) did not significantly alter systolic time intervals, as non-invasively measured haemodynamic parameters, compared to digoxin treatment alone. Thus, nitrendipine 20 mg daily caused a significant increase in plasma digoxin concentrations and in its AUC, which would rarely be of clinical relevance.
Similar articles
-
Nitrendipine/digoxin interaction.J Cardiovasc Pharmacol. 1987;10 Suppl 10:S74-5. J Cardiovasc Pharmacol. 1987. PMID: 2455147
-
Drug interactions with nitrendipine.J Cardiovasc Pharmacol. 1984;6 Suppl 7:S982-5. J Cardiovasc Pharmacol. 1984. PMID: 6085389
-
Dose-dependence of the nifedipine/digoxin interaction?Arch Toxicol Suppl. 1986;9:209-12. doi: 10.1007/978-3-642-71248-7_27. Arch Toxicol Suppl. 1986. PMID: 3468899
-
Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure.J Intern Med. 1989 Apr;225(4):237-9. doi: 10.1111/j.1365-2796.1989.tb00072.x. J Intern Med. 1989. PMID: 2656902 Clinical Trial.
-
Dose-dependence of the nifedipine-digoxin interaction?Clin Pharmacol Ther. 1986 Jan;39(1):35-9. doi: 10.1038/clpt.1986.6. Clin Pharmacol Ther. 1986. PMID: 3943268
Cited by
-
Pharmacokinetic interactions with calcium channel antagonists (Part II).Clin Pharmacokinet. 1991 Dec;21(6):448-60. doi: 10.2165/00003088-199121060-00005. Clin Pharmacokinet. 1991. PMID: 1782739 Review.
-
Calcium antagonists. Drug interactions of clinical significance.Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003. Drug Saf. 1995. PMID: 7495502 Review.
-
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens.AAPS J. 2017 Jan;19(1):298-312. doi: 10.1208/s12248-016-0009-9. Epub 2016 Nov 7. AAPS J. 2017. PMID: 27822600
-
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.Br J Clin Pharmacol. 1988 Nov;26(5):615P-678P. Br J Clin Pharmacol. 1988. PMID: 3207568 Free PMC article. No abstract available.
-
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.Clin Pharmacokinet. 1988 Nov;15(5):295-318. doi: 10.2165/00003088-198815050-00003. Clin Pharmacokinet. 1988. PMID: 2849518 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources